Phase transformations of erythromycin A dihydrate during pelletisation and drying.
暂无分享,去创建一个
Niklas Sandler | Jukka Rantanen | Jouko Yliruusi | Inna Miroshnyk | Jyrki Heinämäki | Meike Römer | J. Rantanen | I. Miroshnyk | N. Sandler | J. Yliruusi | J. Heinämäki | M. Römer
[1] Jean Paul Remon,et al. Extrusion-spheronisation A literature review , 1995 .
[2] Thermal, phase transition and spectral studies in erythromycin pseudopolymorphs: dihydrate and acetone solvate , 2006 .
[3] G. Stephenson,et al. Formation of isomorphic desolvates: creating a molecular vacuum. , 1998, Journal of pharmaceutical sciences.
[4] G. Stephenson,et al. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity. , 1997, Journal of pharmaceutical sciences.
[5] J. Rantanen,et al. Pellet manufacturing by extrusion-spheronization using process analytical technology , 2005, AAPS PharmSciTech.
[6] W. Mccrone,et al. Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.
[7] F. Podczeck,et al. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] Kinam Park,et al. Advances in pharmaceutical materials and processing , 1998 .
[9] J. Rantanen,et al. Insight into Thermally Induced Phase Transformations of Erythromycin A Dihydrate , 2006 .
[10] J. Rantanen,et al. Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction. , 2005, Journal of pharmaceutical and biomedical analysis.
[11] J. Bauer,et al. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. , 1999, Journal of pharmaceutical sciences.
[12] K R Morris,et al. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. , 2001, Advanced drug delivery reviews.
[13] I. Miroshnyk,et al. Influence of solvents on the variety of crystalline forms of erythromycin , 2003, AAPS PharmSci.
[14] Application of NIR spectroscopy in polymorphic analysis: study of pseudo-polymorphs stability. , 2005, Journal of pharmaceutical sciences.
[15] J. Rantanen,et al. Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions. , 2006, Journal of pharmaceutical sciences.
[16] L. Hasznos,et al. Some factors influencing pellet characteristics made by an Extrusion/Spheronisation process Part I.: Effects on size characteristics and moisture content decrease of pellets , 1992 .